Mestinon
Mestinon is a neurology medication containing Pyridostigmine, available as 60mg tablets.
- Category
- Neurology
- Active ingredient
- Pyridostigmine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 60mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Mestinon vary by country.
Details
- Conditions
- Myasthenia gravis
- Therapeutic Class
- Acetylcholinesterase Inhibitor
- Pharmacological Class
- Parasympathomimetic
- Minor Side Effects
- nausea, abdominal cramps, diarrhoea
- Moderate Side Effects
- bradycardia, bronchial secretions, muscle fasciculations
- Dosage Forms
- Tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Originator
- Meda
- Onset Time
- 30–60 minutes
- Duration
- 4–6 hours
- Storage Instructions
- Store at room temperature in a dry place.
- Drug Interactions
- beta-blockers, aminoglycosides
- Age Restrictions
- Suitable for children and adults under specialist guidance.
What you will receive
Mestinon is the originator brand name, made by Meda. We use it here to identify the medicine only; we are not affiliated with Meda and do not ship the original Mestinon.
- You receive a generic equivalent: the same active ingredient (Pyridostigmine) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.